Cite
HARVARD Citation
Ueno, N. et al. (2020). Phase II study of Radium‐223 dichloride combined with hormonal therapy for hormone receptor‐positive, bone‐dominant metastatic breast cancer. Cancer medicine. pp. 1025-1032. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ueno, N. et al. (2020). Phase II study of Radium‐223 dichloride combined with hormonal therapy for hormone receptor‐positive, bone‐dominant metastatic breast cancer. Cancer medicine. pp. 1025-1032. [Online].